NON-SMALL-CELL LUNG
Clinical trials for NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo treatment aims to shrink tumors before lung cancer surgery
Disease control CompletedThis study tested if adding the immunotherapy drug atezolizumab to standard chemotherapy before surgery helps people with early-stage, operable non-small cell lung cancer. Researchers wanted to see if this combination could better shrink tumors and prevent the cancer from coming …
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
Major trial tests new drug combo in fight against advanced lung cancer
Disease control CompletedThis large, completed study tested whether adding the drug aflibercept to standard chemotherapy (docetaxel) helped people with advanced non-small cell lung cancer live longer. It involved over 900 participants whose cancer had worsened after one prior platinum-based treatment. Th…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC